FLS
75
2
JNJ
44
3
CMI
64
5
DOV
68
7
USB
61
11
ROST
52
5
DRI
48
3
VTR
54
5
ES
31
3
AAL
53
-4
L
64
2
ALLE
44
7
BA
49
-3
SO
57
2
NKE
30
2
AMAT
42
6
EW
39
2
DE
56
10
EFX
36
4
COP
54
-2
FLS
75
2
JNJ
44
3
CMI
64
5
DOV
68
7
USB
61
11
ROST
52
5
DRI
48
3
VTR
54
5
ES
31
3
AAL
53
-4
L
64
2
ALLE
44
7
BA
49
-3
SO
57
2
NKE
30
2
AMAT
42
6
EW
39
2
DE
56
10
EFX
36
4
COP
54
-2
Financhill
Back

Cytokinetics Vs. NeuroBo Pharmaceuticals Industry Stock Comparison

Sell
37

CYTK
Cytokinetics

Last Price:
47.68
Seasonality Move:
14.49%
Sell
20

NRBO
NeuroBo Pharmaceuticals

Last Price:
2.35
Seasonality Move:
19.27%
Sell
37
Cytokinetics (CYTK) is a Sell

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $47.67. The Score for CYTK is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
NeuroBo Pharmaceuticals (NRBO) is a Sell

Is NeuroBo Pharmaceuticals a Buy, Sell or Hold?

  • The current NeuroBo Pharmaceuticals [NRBO] share price is $2.35. The Score for NRBO is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • NRBO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $47.67
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing selling pressure, which indicates risk of future bearish movement.

NRBO Stock Price Chart

What is NeuroBo Pharmaceuticals's stock price today?

  • The NeuroBo Pharmaceuticals share price today is $2.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRBO is experiencing selling pressure, which indicates risk of future bearish movement.

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.92 Sell
Relative Strength Index (14 RSI): 34.51 Sell
Chaikin Money Flow: -1683871 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.53 - 55.71) Sell
Bollinger Bands (100): (52.65 - 57.25) Sell

NRBO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 39.46 Sell
Chaikin Money Flow: -9003 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.43 - 2.85) Sell
Bollinger Bands (100): (2.7 - 4.14) Sell

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.2 Sell
20-day SMA: 52.95 Sell
50-day SMA: 53.73 Sell
200-day SMA: 59.65 Sell
8-day EMA: 51.38 Sell
20-day EMA: 52.78 Sell
50-day EMA: 53.72 Sell
200-day EMA: 55.37 Sell

NRBO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.41 Sell
20-day SMA: 2.58 Sell
50-day SMA: 2.83 Sell
200-day SMA: 3.86 Sell
8-day EMA: 2.42 Sell
20-day EMA: 2.55 Sell
50-day EMA: 2.84 Sell
200-day EMA: 4.72 Sell

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.35 per share, and an increase next year of $0.07 per share.

NeuroBo Pharmaceuticals Earnings Growth & NRBO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NeuroBo Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):